Predictive Factors and Outcome in Medical Thoracoscopy

Pleuritis Clinical Trial

Official title:

Predictive Factors and Outcome in Medical Thoracoscopy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02288065
• Other study ID #: S561430
• Status: Completed
• Phase: N/A
• First received: November 4, 2014
• Last updated: December 29, 2016
• Start date: January 2014
• Est. completion date: December 2016

Study information

• Verified date: December 2016
• Source: Katholieke Universiteit Leuven
• Contact: n/a
• Is FDA regulated: No
• Health authority: Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
• Study type: Observational

Clinical Trial Summary

Retrospective survey for factors predicting the outcome of medical thoracoscopy

Description:

Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Recruitment information / eligibility

• Status: Completed
• Enrollment: 155
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• progressive malignancy

• pleuritis

Exclusion Criteria:

• respiratory failure

• unable to consent

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Pleuritis

Intervention

Drug:
• sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.

Locations

Country	Name	City	State
Belgium	UZ Leuven	Leuven

Sponsors (1)

Lead Sponsor	Collaborator
Katholieke Universiteit Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chest X-ray	radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)	3 months	No
Secondary	time interval	survival in months	12 months	No